COVID-19 case-fatality variations with application to the Middle East countries

Area of Science:

• Epidemiology
• Public Health
• Biostatistics

Background:

• Accurate assessment of pandemic severity, particularly case fatality rates (CFR), is crucial for effective public health response.
• Existing CFR estimations often fail to capture the dynamic nature of disease lethality throughout an outbreak.
• Understanding temporal changes in fatality is essential for timely policy adjustments and resource allocation.

Purpose of the Study:

• To develop and validate novel metrics for measuring the dynamic lethality of COVID-19.
• To analyze variations in COVID-19 case fatality rates across selected Middle East countries.
• To provide a more nuanced understanding of pandemic deadliness beyond static CFR calculations.

Main Methods:

• Collected daily COVID-19 case and death data from MENA countries.
• Developed a fixed-effects panel data model to link deaths to lagged case numbers.
• Introduced a second fatality measure based on change point analysis of cases and deaths.
• Estimated the time lag between infection and death for hospitalized patients.

Main Results:

• Identified significant variations in COVID-19 lethality among Middle East nations.
• Attributed observed lethality differences to potential disparities in healthcare quality.
• Demonstrated that novel measures effectively capture temporal dynamics of pandemic deadliness.
• Showcased limitations of crude CFR in reflecting real-time pandemic severity.

Conclusions:

• The developed fatality measures offer superior insights into pandemic dynamics compared to traditional CFR.
• Healthcare system capacity significantly influences observed COVID-19 case fatality rates.
• Continuous monitoring of dynamic fatality metrics is vital for adaptive pandemic management.
• Findings underscore the need for standardized data collection and reporting in public health surveillance.